These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 8315383)

  • 1. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
    Chicz RM; Urban RG; Gorga JC; Vignali DA; Lane WS; Strominger JL
    J Exp Med; 1993 Jul; 178(1):27-47. PubMed ID: 8315383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
    J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.
    Khalil-Daher I; Boisgérault F; Feugeas JP; Tieng V; Toubert A; Charron D
    Eur J Immunol; 1998 Nov; 28(11):3840-9. PubMed ID: 9842927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.
    Childerstone A; Altmann D; Haron JA; Wilkinson D; Trowsdale J; Lehner T
    J Immunol; 1991 Mar; 146(5):1463-9. PubMed ID: 1993839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
    Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
    Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.
    Chicz RM; Lane WS; Robinson RA; Trucco M; Strominger JL; Gorga JC
    Int Immunol; 1994 Nov; 6(11):1639-49. PubMed ID: 7865457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
    Hammer J; Valsasnini P; Tolba K; Bolin D; Higelin J; Takacs B; Sinigaglia F
    Cell; 1993 Jul; 74(1):197-203. PubMed ID: 8334703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands.
    Muixí L; Carrascal M; Alvarez I; Daura X; Martí M; Armengol MP; Pinilla C; Abian J; Pujol-Borrell R; Jaraquemada D
    J Immunol; 2008 Jul; 181(1):795-807. PubMed ID: 18566446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs.
    O'Sullivan D; Arrhenius T; Sidney J; Del Guercio MF; Albertson M; Wall M; Oseroff C; Southwood S; Colón SM; Gaeta FC
    J Immunol; 1991 Oct; 147(8):2663-9. PubMed ID: 1717570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
    Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
    J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
    Ovsyannikova IG; Vierkant RA; Poland GA
    Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.